Total number of projects: 2
As coordinator: 0
As participant: 1
Sole participant: 1
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2017 | 50.000 | 0 | 50.000 | 1 | ||
2013 | 0 | 5.691.950 | 474.250 | 1 |
Total number of partners: 4
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 4
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2017-03-01 | Development of the Cyclin-Dependent Kinase Inhibitor VS2-370 to Target HIV-associated Malignancies and to Purge Viral Reservoir | THUNDER | coordinator | 50.000 | 1 |
2013-09-01 | Targeting the HIV-1 Nucleocapsid Protein to fight Antiretroviral Drug Resistance | THINPAD | participant | 5.691.950 | 5 |